Zero-crossing derivative spectrophotometry for the determination of haloperidol in presence of parabens. 1998

S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
Laboratoire National de Contrôle des Médicaments, Bab Saadoun, Tunis, Tunisia.

First derivative spectrophotometry with a zero-crossing technique of measurement is used for the quantitative determination of haloperidol in the presence of methylparaben and propylparaben, which is added as antimicrobial preservatives in pharmaceuticals. This technique permits the quantification of haloperidol in the presence of parabens, with closely overlapping spectral bands, and without any separation step. Linear calibration graphs of first derivative values (at 255.2 nm for haloperidol) versus concentration (in the range 4.0-20.0 micrograms ml-1) were obtained with negligible intercepts. Relative standard deviation of 0.83% was obtained for intra-day precision and 1.86% for inter-day precision. The recovery of haloperidol in synthetic mixtures with parabens and pharmaceutical dosage forms is also reported.

UI MeSH Term Description Entries
D010226 Parabens Methyl, propyl, butyl, and ethyl esters of p-hydroxybenzoic acid. They have been approved by the FDA as antimicrobial agents for foods and pharmaceuticals. (From Hawley's Condensed Chemical Dictionary, 11th ed, p872) 4-Hydroxybenzoic Acids,Paraben,para-Hydroxybenzoic Acids,4 Hydroxybenzoic Acids,para Hydroxybenzoic Acids
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D013053 Spectrophotometry The art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum.
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016014 Linear Models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Linear Regression,Log-Linear Models,Models, Linear,Linear Model,Linear Regressions,Log Linear Models,Log-Linear Model,Model, Linear,Model, Log-Linear,Models, Log-Linear,Regression, Linear,Regressions, Linear

Related Publications

S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
January 1992, Yao xue xue bao = Acta pharmaceutica Sinica,
S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
February 1994, Journal of pharmaceutical and biomedical analysis,
S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
July 1998, Journal of pharmaceutical and biomedical analysis,
S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
July 1988, Journal of pharmaceutical sciences,
S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
October 1987, Clinical chemistry,
S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
March 1995, Journal of pharmaceutical and biomedical analysis,
S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
June 2002, Journal of pharmaceutical and biomedical analysis,
S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
August 2000, Clinica chimica acta; international journal of clinical chemistry,
S Ouanês, and M Kallel, and H Trabelsi, and F Safta, and K Bouzouita
July 1998, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!